Disclosed positions

Estimated from their latest filings — positions may have changed since

$27.82M

combined est. value

Stock	Shares	Price	Value	Weight	As of
TRDAEntrada Therapeutics, Inc.	3,939,905	$7.06	$27.82M	100%	2026-07-31

TRDA

Entrada Therapeutics, Inc.

$27.82M

3,939,905 sh

All filings on record

Every Form 4 transaction we track for this filer

all 11buys 0sells 11

Stock	Transaction	Date	~6mo later
TRDAEntrada Therapeutics, Inc.	Sell $11.8K · 1,718 sh	2026-07-31	—
TRDAEntrada Therapeutics, Inc.	Sell $795.3K · 114,756 sh	2026-07-30	—
TRDAEntrada Therapeutics, Inc.	Sell $1.76M · 200,000 sh	2025-11-14	—
TRDAEntrada Therapeutics, Inc.	Sell $52.0K · 6,935 sh	2025-07-09	—
TRDAEntrada Therapeutics, Inc.	Sell $150.5K · 20,065 sh	2025-07-09	—
TRDAEntrada Therapeutics, Inc.	Sell $45.7K · 6,422 sh	2025-07-01	—
TRDAEntrada Therapeutics, Inc.	Sell $132.3K · 18,578 sh	2025-07-01	—
TRDAEntrada Therapeutics, Inc.	Sell $43.8K · 6,422 sh	2025-06-30	—
TRDAEntrada Therapeutics, Inc.	Sell $126.6K · 18,578 sh	2025-06-30	—
TRDAEntrada Therapeutics, Inc.	Sell $133.1K · 19,265 sh	2025-06-27	—
TRDAEntrada Therapeutics, Inc.	Sell $385.1K · 55,735 sh	2025-06-27	—

TRDASell

2026-07-31 · Entrada Therapeutics, Inc.

$11.8K

—

TRDASell

2026-07-30 · Entrada Therapeutics, Inc.

$795.3K

—

TRDASell

2025-11-14 · Entrada Therapeutics, Inc.

$1.76M

—

TRDASell

2025-07-09 · Entrada Therapeutics, Inc.

$52.0K

—

TRDASell

2025-07-09 · Entrada Therapeutics, Inc.

$150.5K

—

TRDASell

2025-07-01 · Entrada Therapeutics, Inc.

$45.7K

—

TRDASell

2025-07-01 · Entrada Therapeutics, Inc.

$132.3K

—

TRDASell

2025-06-30 · Entrada Therapeutics, Inc.

$43.8K

—

TRDASell

2025-06-30 · Entrada Therapeutics, Inc.

$126.6K

—

TRDASell

2025-06-27 · Entrada Therapeutics, Inc.

$133.1K

—

TRDASell

2025-06-27 · Entrada Therapeutics, Inc.

$385.1K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.